Alembic Pharma net profit drops 40% to Rs 176 crore in Q3FY22 - Business News: Latest News & Videos about market and economy | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Alembic Pharma net profit drops 40% to Rs 176 crore in Q3FY22

"India business is going to grow, and continue to grow faster than our represented market, the initiatives we have taken in last few years and the Omicron coming up in the last quarter - some of the COVID related therapies like Azithromycin have seen sharp uptake in January," Pranav Amin, managing director, international business at Alembic Pharma told ET.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...

Post Top Ad